{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:27:06Z","timestamp":1740122826461,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DA021525","U01-DA021525"],"award-info":[{"award-number":["U01-DA021525","U01-DA021525"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CGS-D","New Investigator Award","New Investigator Award","FDN-154320"],"award-info":[{"award-number":["CGS-D","New Investigator Award","New Investigator Award","FDN-154320"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["Scholar Award","Scholar Award","Health Professional Award"],"award-info":[{"award-number":["Scholar Award","Scholar Award","Health Professional Award"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"crossref","award":["Steven Diamond Professorship in Addiction Care Innovation"],"award-info":[{"award-number":["Steven Diamond Professorship in Addiction Care Innovation"]}],"id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10461-021-03543-y","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:03:15Z","timestamp":1641168195000},"page":"1933-1942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the Temporality Between Transitions onto Opioid Agonist Therapy and Engagement with Antiretroviral Therapy in a Cohort of HIV-Positive People Who Use Opioids Daily"],"prefix":"10.1007","volume":"26","author":[{"given":"Sanjana","family":"Mitra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonaid","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Afiqah","family":"Mohd Salleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-8891","authenticated-orcid":false,"given":"Lindsey","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"3543_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12879-015-0913-0","volume":"15","author":"P Azar","year":"2015","unstructured":"Azar P, Wood E, Nguyen P, Luma M, Montaner J, Kerr T, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis. 2015;15:193.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"3543_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10461-008-9489-7","volume":"14","author":"M Malta","year":"2010","unstructured":"Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731\u201347.","journal-title":"AIDS Behav"},{"key":"3543_CR3","unstructured":"Public Health Agency of Canada. Summary of Key Findings from I-Track Phase 3 (2010\u20132012). Canada; 2012."},{"issue":"12","key":"3543_CR4","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207.","journal-title":"Lancet Glob Health"},{"key":"3543_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12879-015-1255-7","volume":"15","author":"P Bach","year":"2015","unstructured":"Bach P, Wood E, Dong H, Guillemi S, Kerr T, Montaner J, et al. Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study. BMC Infect Dis. 2015;15:537.","journal-title":"BMC Infect Dis"},{"key":"3543_CR6","unstructured":"BC Centre for Excellence in HIV\/AIDS. HIV Monitoring Quarterly Report 2018. http:\/\/stophivaids.ca\/qmr\/2018-Q1\/#\/bc."},{"issue":"9","key":"3543_CR7","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1503\/cmaj.170958","volume":"190","author":"J Bruneau","year":"2018","unstructured":"Bruneau J, Ahamad K, Goyer ME, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. Can Med Assoc J. 2018;190(9):E247\u201357.","journal-title":"Can Med Assoc J"},{"key":"3543_CR8","first-page":"CD0002207","volume":"3","author":"RP Mattick","year":"2004","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2004;3:CD0002207.","journal-title":"Cochrane Database Syst Rev"},{"key":"3543_CR9","unstructured":"Health Canada. Methadone Maintenance Treatment. 2002."},{"issue":"3","key":"3543_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/QAI.0000000000001827","volume":"79","author":"A Mazhnaya","year":"2018","unstructured":"Mazhnaya A, Marcus R, Bojko MJ, Zelenev A, Makarenko I, Pykalo I, et al. Opioid agonist treatment and improved outcomes at each stage of the HIV treatment cascade in people who inject drugs in Ukraine. J Acquir Immune Defic Syndr. 2018;79(3):288\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"3543_CR11","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1377\/hlthaff.2011.0663","volume":"30","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Montaner J. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Affairs (Project Hope). 2011;30(8):1411\u20139.","journal-title":"Health Affairs (Project Hope)"},{"issue":"8","key":"3543_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/cid\/ciw416","volume":"63","author":"AJ Low","year":"2016","unstructured":"Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63(8):1094\u2013104.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3543_CR13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/QAD.0000000000000642","volume":"29","author":"B Nosyk","year":"2015","unstructured":"Nosyk B, Min JE, Colley G, Lima VD, Yip B, Milloy MJ, et al. The causal effect of opioid substitution treatment on HAART medication refill adherence. AIDS (London, England). 2015;29(8):965\u201373.","journal-title":"AIDS (London, England)"},{"issue":"12","key":"3543_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/apc.2013.0139","volume":"27","author":"S Linnemayr","year":"2013","unstructured":"Linnemayr S, Glick P, Kityo C, Mugyeni P, Wagner G. Prospective cohort study of the impact of antiretroviral therapy on employment outcomes among HIV clients in Uganda. AIDS Patient Care STDS. 2013;27(12):707\u201314.","journal-title":"AIDS Patient Care STDS"},{"issue":"11","key":"3543_CR15","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1080\/09540120902889926","volume":"21","author":"J Beard","year":"2009","unstructured":"Beard J, Feeley F, Rosen S. Economic and quality of life outcomes of antiretroviral therapy for HIV\/AIDS in developing countries: a systematic literature review. AIDS Care. 2009;21(11):1343\u201356.","journal-title":"AIDS Care"},{"issue":"18","key":"3543_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1097\/QAD.0b013e328359b809","volume":"26","author":"K Palar","year":"2012","unstructured":"Palar K, Wagner G, Ghosh-Dastidar B, Mugyenyi P. Role of antiretroviral therapy in improving food security among patients initiating HIV treatment and care. AIDS (London, England). 2012;26(18):2375\u201381.","journal-title":"AIDS (London, England)"},{"issue":"9","key":"3543_CR17","doi-asserted-by":"publisher","first-page":"e12731","DOI":"10.1371\/journal.pone.0012731","volume":"5","author":"S Rosen","year":"2010","unstructured":"Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, et al. Economic outcomes of patients receiving antiretroviral therapy for HIV\/AIDS in South Africa are sustained through three years on treatment. PLoS ONE. 2010;5(9):e12731.","journal-title":"PLoS ONE"},{"issue":"3","key":"3543_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/QAD.0000000000000053","volume":"28","author":"S Rosen","year":"2014","unstructured":"Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, et al. Effect of antiretroviral therapy on patients\u2019 economic well being: five-year follow-up. AIDS (London, England). 2014;28(3):417\u201324.","journal-title":"AIDS (London, England)"},{"issue":"9","key":"3543_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/PSY.0b013e31826629db","volume":"74","author":"GJ Wagner","year":"2012","unstructured":"Wagner GJ, Ghosh-Dastidar B, Garnett J, Kityo C, Mugyenyi P. Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda. Psychosom Med. 2012;74(9):883\u201390.","journal-title":"Psychosom Med"},{"issue":"1","key":"3543_CR20","doi-asserted-by":"publisher","first-page":"21585","DOI":"10.7448\/IAS.20.1.21585","volume":"20","author":"V Haldane","year":"2017","unstructured":"Haldane V, Cervero-Liceras F, Chuah FL, Ong SE, Murphy G, Sigfrid L, et al. Integrating HIV and substance use services: a systematic review. J Int AIDS Soc. 2017;20(1):21585.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"3543_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA, Palepu A, Cornelisse PG, Yip B, O\u2019Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. J Am Med Assoc. 1998;280(6):547\u20139.","journal-title":"J Am Med Assoc"},{"issue":"5","key":"3543_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/jama.300.5.550","volume":"300","author":"E Wood","year":"2008","unstructured":"Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BD, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. J Am Med Assoc. 2008;300(5):550\u20134.","journal-title":"J Am Med Assoc"},{"key":"3543_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drugalcdep.2018.04.026","volume":"189","author":"ME Socias","year":"2018","unstructured":"Socias ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E, et al. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006\u20132016. Drug Alcohol Depend. 2018;189:90\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"3543_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/cid\/civ929","volume":"62","author":"MJ Milloy","year":"2016","unstructured":"Milloy MJ, Wood E, Kerr T, Hogg B, Guillemi S, Harrigan PR, et al. Increased prevalence of controlled viremia and decreased rates of HIV drug resistance among HIV-positive people who use illicit drugs during a community-wide treatment-as-prevention initiative. Clin Infect Dis. 2016;62(5):640\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3543_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","volume":"138","author":"G Maldonado","year":"1993","unstructured":"Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923\u201336.","journal-title":"Am J Epidemiol"},{"issue":"18","key":"3543_CR26","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1097\/QAD.0000000000000853","volume":"29","author":"L Richardson","year":"2015","unstructured":"Richardson L, Kerr T, Dobrer S, Puskas C, Guillemi S, Montaner J, et al. Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting. AIDS (London, England). 2015;29(18):2487\u201395.","journal-title":"AIDS (London, England)"},{"issue":"5","key":"3543_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/09540120412331319714","volume":"17","author":"J Jelsma","year":"2005","unstructured":"Jelsma J, Maclean E, Hughes J, Tinise X, Darder M. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care. 2005;17(5):579\u201388.","journal-title":"AIDS Care"},{"issue":"9","key":"3543_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/09540121.2017.1300634","volume":"29","author":"A Guise","year":"2017","unstructured":"Guise A, Seguin M, Mburu G, McLean S, Grenfell P, Islam Z, et al. Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences. AIDS Care. 2017;29(9):1119\u201328.","journal-title":"AIDS Care"},{"issue":"7","key":"3543_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/09540121.2015.1009362","volume":"27","author":"CW Holtzman","year":"2015","unstructured":"Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, et al. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen\u2019s Behavioral Model. AIDS Care. 2015;27(7):817\u201328.","journal-title":"AIDS Care"},{"key":"3543_CR30","first-page":"1","volume":"2019","author":"A Magaco","year":"2019","unstructured":"Magaco A, Dovel K, Cataldo F, Nhassengo P, Hoffman R, Nerua L, et al. \u201cGood health\u201d as a barrier and facilitator to ART initiation: a qualitative study in the era of test-and-treat in Mozambique. Cult Health Sex. 2019;2019:1\u201315.","journal-title":"Cult Health Sex"},{"key":"3543_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijid.2016.03.022","volume":"46","author":"LB Mlunde","year":"2016","unstructured":"Mlunde LB, Sunguya BF, Mbwambo JK, Ubuguyu OS, Yasuoka J, Jimba M. Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review. Int J Infect Dis. 2016;46:27\u201333.","journal-title":"Int J Infect Dis"},{"key":"3543_CR32","first-page":"108342","volume":"2020","author":"NA Mohd Salleh","year":"2020","unstructured":"Mohd Salleh NA, Voon P, Karamouzian M, Milloy MJ, Richardson L. Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: a systematic review of trials and observational studies. Drug Alcohol Depend. 2020;2020:108342.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3543_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13722-019-0149-1","volume":"14","author":"J Carter","year":"2019","unstructured":"Carter J, Zevin B, Lum PJ. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addict Sci Clin Pract. 2019;14(1):20.","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"3543_CR34","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.drugpo.2013.05.005","volume":"24","author":"C Strike","year":"2013","unstructured":"Strike C, Millson M, Hopkins S, Smith C. What is low threshold methadone maintenance treatment? Int J Drug Policy. 2013;24(6):e51\u20136.","journal-title":"Int J Drug Policy"},{"key":"3543_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","volume":"161","author":"G Kourounis","year":"2016","unstructured":"Kourounis G, Richards BD, Kyprianou E, Symeonidou E, Malliori MM, Samartzis L. Opioid substitution therapy: lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3543_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13722-020-00186-7","volume":"15","author":"A Scheibe","year":"2020","unstructured":"Scheibe A, Shelly S, Gerardy T, von Homeyer Z, Schneider A, Padayachee K, et al. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addict Sci Clin Pract. 2020;15(1):13.","journal-title":"Addict Sci Clin Pract"},{"issue":"9","key":"3543_CR37","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2105\/AJPH.81.9.1185","volume":"81","author":"SR Yancovitz","year":"1991","unstructured":"Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991;81(9):1185\u201391.","journal-title":"Am J Public Health"},{"issue":"2","key":"3543_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1521\/aeap.2007.19.2.124","volume":"19","author":"P Millson","year":"2007","unstructured":"Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, et al. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev. 2007;19(2):124\u201336.","journal-title":"AIDS Educ Prev"},{"issue":"5","key":"3543_CR39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","volume":"91","author":"MW Langendam","year":"2001","unstructured":"Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health. 2001;91(5):774\u201380.","journal-title":"Am J Public Health"},{"key":"3543_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2015.08.037","volume":"156","author":"S Nolan","year":"2015","unstructured":"Nolan S, Hayashi K, Milloy MJ, Kerr T, Dong H, Lima VD, et al. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting. Drug Alcohol Depend. 2015;156:57\u201361.","journal-title":"Drug Alcohol Depend"},{"key":"3543_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","volume":"198","author":"JJ Wyse","year":"2019","unstructured":"Wyse JJ, Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, et al. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug Alcohol Depend. 2019;198:70\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"3543_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/heapol\/czw149","volume":"32","author":"N Watt","year":"2017","unstructured":"Watt N, Sigfrid L, Legido-Quigley H, Hogarth S, Maimaris W, Otero-Garcia L, et al. Health systems facilitators and barriers to the integration of HIV and chronic disease services: a systematic review. Health Policy Plan. 2017;32(4):13\u201326.","journal-title":"Health Policy Plan"},{"issue":"3","key":"3543_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1300\/J465v27n03_03","volume":"27","author":"LE Sullivan","year":"2006","unstructured":"Sullivan LE, Tetrault J, Bangalore D, Fiellin DA. Training HIV physicians to prescribe buprenorphine for opioid dependence. Subst Abuse. 2006;27(3):13\u20138.","journal-title":"Subst Abuse"},{"issue":"3","key":"3543_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/add.14436","volume":"114","author":"CM Jones","year":"2019","unstructured":"Jones CM, McCance-Katz EF. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Addiction (Abingdon, England). 2019;114(3):471\u201382.","journal-title":"Addiction (Abingdon, England)"},{"key":"3543_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51:253\u201363.","journal-title":"Drug Alcohol Depend"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03543-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T11:43:42Z","timestamp":1651059822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03543-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3543"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03543-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"22 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M-J Milloy\u2019s institution (the University of British Columbia) has received an unstructured gift from NG Biomed Ltd., a private firm seeking a government license to produce medical cannabis, to support him. M-JM is also the Canopy Growth professor of cannabis science at the University of British Columbia, a position established by arms\u2019 length gifts from Canopy Growth, a licensed producer of cannabis, and the Government of British Columbia\u2019s Ministry of Mental Health and Addictions. He has no personal financial relationships (e.g., employment, stock ownership, consulting, etc.) with the cannabis industry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Providence Health Care\/University of British Columbia Research Ethics Boards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All cohort participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}